Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease |
Kim, Hyunho
(Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital)
Sung, Jinmo (Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital) Kim, Hyunsuk (Internal Medicine, Hallym University Medical Center, Chuncheon Sacred Heart Hospital) Ryu, Hyunjin (Department of Internal Medicine, Seoul National University College of Medicine) Park, Hayne Cho (Department of Internal Medicine, Hallym University Medical Center, Kangnam Sacred Heart Hospital) Oh, Yun Kyu (Department of Internal Medicine, Seoul National University Boramae Medical Center) Lee, Hyun-Seob (Genomics Core Facility, Department of Transdisciplinary Research and Collaboration, Biomedical Research Institute, Seoul National University Hospital) Oh, Kook-Hwan (Department of Internal Medicine, Seoul National University College of Medicine) Ahn, Curie (Department of Internal Medicine, Seoul National University College of Medicine) |
1 | Peters DJ and Breuning MH (2001) Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 358, 1439-1444 DOI |
2 | Harris PC and Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60, 321-337 DOI |
3 | Ghata J and Cowley BD Jr (2017) Polycystic Kidney Disease. Compr Physiol 7, 945-975 DOI |
4 | Sutters M and Germino GG (2003) Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141, 91-101 DOI |
5 | Watnick TJ, Piontek KB, Cordal TM et al (1997) An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet 6, 1473-1481 DOI |
6 | Rossetti S, Hopp K, Sikkink RA et al (2012) Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol 23, 915-933 DOI |
7 | Pei Y (2001) A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 7, 151-156 DOI |
8 | Bodnar AG, Ouellette M, Frolkis M et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 DOI |
9 | Counter CM, Hahn WC, Wei W et al (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A 95, 14723-14728 DOI |
10 | Lee KM, Choi KH and Ouellette MM (2004) Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45, 33-38 DOI |
11 | Liekens S, Schols D and Hatse S (2010) CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr Pharm Des 16, 3903-3920 DOI |
12 | Ouellette MM, McDaniel LD, Wright WE, Shay JW and Schultz RA (2000) The establishment of telomeraseimmortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet 9, 403-411 DOI |
13 | Hein J, Boichuk S, Wu J et al (2009) Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J Virol 83, 117-127 DOI |
14 | Shirozu M, Nakano T, Inazawa J et al (1995) Structure and chromosomal localization of the human stromal cellderived factor 1 (SDF1) gene. Genomics 28, 495-500 DOI |
15 | Nagasawa T (2014) CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4. J Mol Med 92, 433-439 DOI |
16 | Sanchez-Martin L, Sanchez-Mateos P, Cabanas C (2013) CXCR7 impact on CXCL12 biology and disease. Trends Mol Med 19, 12-22 DOI |
17 | Guyon A (2014) CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Front Cell Neurosci 8, 65 DOI |
18 | Ghanem I, Riveiro ME, Paradis V, Faivre S, de Parga PM and Raymond E (2014) Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis. Am J Transl Res 6, 340-352 |
19 | Scala S (2015) Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment. Clin Cancer Res 21, 4278-4285 DOI |
20 | Herbert BS, Grimes BR, Xu WM et al (2013) A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1. PLoS One 8, e55191 DOI |
21 | Jo HS, Eum WS, Park EY et al (2017) Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease. BMB Rep 50, 460-465 DOI |
22 | Tan YC, Blumenfeld JD, Anghel R et al (2009) Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat 30, 264-273 DOI |
![]() |